05/03/2021

FDA Expected to Okay Pfizer Vaccine for Youth 12 and Older Within a Week

A federal official has confirmed this

The U.S. Food and Drug Administration is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for young adults 12 and older by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.

The announcement is set to come barely a month after the company found that its shot, which is already authorized for those ages 16 and older, also provided protection for the younger group.

The federal official, speaking on the condition of anonymity to preview the FDA’s action, said the agency was expected to expand its emergency use authorization for Pfizer’s two-dose vaccine by early next week and perhaps even sooner. The person familiar with the process, who spoke on the condition of anonymity to discuss internal matters, confirmed the timeline and added that it is expected that the FDA will approve Pfizer’s use by even younger children sometime this fall.

Please select this link to read the complete article from The Los Angeles Times.